Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in MDGL — Madrigal Pharmaceuticals, Inc.

CIK 1452765 NEW YORK, NY

Position in MDGL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$210,484
-$1,100,186 QoQ
Shares Held
392
-93.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#314
of 411 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MDGL Over Time

Shares Held

Position Value (USD)

Derivatives in MDGL

reported options exposure · as of Sep 30, 2024
CallValue
$5,772,384
CallShares
27,200
PutValue
$4,435,398
PutShares
20,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $5,249,889 across 19 Biotechnology names. MDGL ranks #10 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MDGL

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $210,484 392
2024-09-30 $1,310,670 6,176
2024-09-30 $4,435,398 20,900
2024-09-30 $5,772,384 27,200
2024-06-30 $3,698,112 13,200
2024-06-30 $444,053 1,585
2024-06-30 $6,947,968 24,800
2024-03-31 $5,233,984 19,600
2024-03-31 $10,761,712 40,300
2024-03-31 $1,300,484 4,870
2023-12-31 $5,414,292 23,400
2023-12-31 $7,589,264 32,800
2023-12-31 $928,065 4,011
2023-09-30 $2,745,552 18,800
2023-09-30 $919,759 6,298
2023-09-30 $1,986,144 13,600